RT @dranilUSW: Meta-analysis concludes that sulphonylureas (SUs) compared to metformin increase risk of acute MIs by 24%. SUs in this analy…
7,381 followers
9 followers
Meta-analysis concludes that sulphonylureas (SUs) compared to metformin increase risk of acute MIs by 24%. SUs in this analysis mostly 1st/2nd generation SUs eg. glyburide (glibenclamide). Some disagree on class effect eg. for gliclazide modified release h
1,749 followers
RT @ScreamTheYellow: Cardiovascular risk associated with the use of glitazones, metformin and sufonylureas: meta-analysis of published… htt…
1,539 followers
Cardiovascular risk associated with the use of glitazones, metformin and sufonylureas: meta-analysis of published… https://t.co/qqAc8mVyhE